| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 05/01/2003 | US20030083505 Benzenedicarboxylic acid derivatives |
| 05/01/2003 | US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives |
| 04/29/2003 | US6555689 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 04/24/2003 | US20030078437 Novel benzamidoxime derivatives, intermediates and process for their preparation, and their use as fungicides |
| 04/24/2003 | US20030078428 Phenylamino benzhydroxamic acid derivatives inhibit certain dual specificity kinase enzymes involved in proliferative diseases such as cancer, psoriasis and restenosis; inhibit the phosphorylation of MAP kinase by MEK |
| 04/24/2003 | US20030078302 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 04/23/2003 | EP1304322A2 Carboxylic acid compound and use thereof |
| 04/23/2003 | EP1102739B1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 04/23/2003 | EP0993442B1 Hydrazine derivatives |
| 04/22/2003 | US6552223 N-hydroxacylamino compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/22/2003 | US6552200 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 04/22/2003 | US6552065 Antiproliferative agents |
| 04/16/2003 | EP1301472A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 04/16/2003 | EP1301458A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 04/16/2003 | CN1411436A Hydroxamic acid derivative as inhibitor of formation of soluble human CD23 |
| 04/15/2003 | US6548694 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 04/15/2003 | US6548675 1-Cyclopropylcarbonyl-2-hydroxy(optional),4-isopropylbenzene used as starting materials for 1-((2-hydroxy(optional),4-alkylphenyl)carbonylalkyl-),4-(diphenylmethyl -)piperidine derivatives; antihistamines; antiallergens; bronchodilators |
| 04/10/2003 | WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 04/10/2003 | US20030069447 Acetal hydroxylamine compounds |
| 04/09/2003 | EP0874808B1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
| 04/09/2003 | CN1105100C Compound with anti-inflammatory and immunosuppressive activities |
| 04/08/2003 | US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders |
| 04/03/2003 | US20030065176 Anticoagulant; cardiovascular disorders |
| 04/02/2003 | CN1104413C Phenylalkylcarboxylic acid derivatives |
| 04/02/2003 | CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them |
| 04/01/2003 | US6541661 Inhibitors of histone deacetylase |
| 04/01/2003 | US6541473 Resorcinol derivatives |
| 04/01/2003 | US6541276 Nucleophilic reaction of alkoxyamine |
| 03/27/2003 | WO2003024922A1 Hydroxyfattysulfonic acid analogs |
| 03/27/2003 | WO2003024390A2 Hydroxyeicosenoic acid analogs |
| 03/27/2003 | US20030060459 Diamines as modulators of chemokine receptor activity |
| 03/27/2003 | US20030059905 Multistage process for the preparation of highly pure deferoxamine mesylate salt |
| 03/27/2003 | CA2460358A1 Hydroxyfattysulfonic acid analogs |
| 03/27/2003 | CA2460263A1 Hydroxyeicosenoic acid analogs |
| 03/26/2003 | EP1294741A2 Dipeptide inhibitors for the blood-clotting factor xa |
| 03/20/2003 | WO2003022810A1 3-amino carbonyl-substituted benzoylcyclohexanediones that can be used as herbicides |
| 03/19/2003 | EP1292601A2 Naaladase inhibitors for treating retinal disorders and glaucoma |
| 03/19/2003 | EP1292563A2 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 03/18/2003 | CA2162708C Bicyclic amide derivatives and their use as muscle relaxants |
| 03/13/2003 | WO2002050019A3 Diamines as modulators of chemokine receptor activity |
| 03/12/2003 | EP1289939A1 Phenylglycine derivatives |
| 03/12/2003 | EP1289935A1 Excitatory amino acid receptor modulators |
| 03/12/2003 | EP1012144B1 Method for producing (hetero)aromatic hydroxylamines |
| 03/12/2003 | EP0977730B1 Amino acid derivatives inhibiting extracellular matrix metalloproteinase and tnf alpha release |
| 03/12/2003 | EP0672031B1 Catechol diethers as selective pde iv inhibitors |
| 03/11/2003 | US6531472 Tetralone derivatives |
| 03/06/2003 | WO2002098901A3 Peptide deformylase inhibitors |
| 03/06/2003 | US20030045579 Compounds and compositions for delivering active agents |
| 03/05/2003 | EP1286953A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 03/05/2003 | CN1400969A Fused imidazolium derivatives |
| 02/26/2003 | WO2002020467A1 Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy -4(s)-[n-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient |
| 02/26/2003 | EP0885187B1 Diphenylethers, process and intermediate products for their preparation, and their use |
| 02/26/2003 | CA2419744A1 A novel crystal of n-hydroxy-2(s)-methyl-5-ethoxymethoxy-4(s)-¬n-(4-phenoxyphenylcarbonyl)amino|pentanamide and a method for the preparation thereof and a pharmaceutical agent comprising the same as active ingredient |
| 02/25/2003 | US6525020 For drug delivery |
| 02/20/2003 | US20030036534 Naaladase inhibitors for treating retinal disorders and glaucoma |
| 02/19/2003 | EP1283711A1 Peptide deformylase inhibitors |
| 02/19/2003 | CN1101807C 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 02/18/2003 | US6521650 Amines as pharmaceutical agents |
| 02/14/2003 | WO2002018326A1 Novel propenohydroxamic acid derivatives |
| 02/14/2003 | CA2423733A1 Novel propenohydroxamic acid derivatives |
| 02/13/2003 | WO2003011851A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/13/2003 | WO2002068379A3 Novel bifunctional chelating compounds containing hydroxamic acid residues |
| 02/13/2003 | US20030032803 Novel amide derivatives as inhibitors of matrix metalloproteinases, TNF-alpha, and aggrecanase |
| 02/13/2003 | CA2449804A1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/12/2003 | EP1282413A1 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | CN1101374C Synthesis of alpha-chloro or fluoro ketones |
| 02/11/2003 | US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 02/06/2003 | US20030027861 6-Methoxy-2-naphthylacetic acid prodrugs |
| 02/06/2003 | US20030027860 6-Methoxy-2-naphthylacetic acid prodrugs |
| 02/05/2003 | EP1280764A2 Inhibitors of histone deacetylase |
| 02/04/2003 | US6514925 O-substituted N,N-diacylhydroxylamine bleach activators and compositions employing the same |
| 01/30/2003 | WO2003002522A8 Peptide deformylase inhibitors |
| 01/29/2003 | EP1278719A1 Naphthamide neurokinin antagonists for use as medicaments |
| 01/28/2003 | US6512143 Salts of N-tert-butylhydroxylamine |
| 01/28/2003 | US6512123 Antiproliferative agents |
| 01/28/2003 | US6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/23/2003 | WO2003005956A2 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 01/23/2003 | WO2002022559A3 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 01/23/2003 | US20030018062 Deacetylase inhibitors |
| 01/23/2003 | CA2453346A1 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 01/21/2003 | US6509501 Benzamidoxime derivatives, intermediates and processes for their preparation, and their use as fungicides |
| 01/16/2003 | US20030013762 6-methoxy-2-naphthylacetic acid prodrugs |
| 01/16/2003 | US20030013757 Aromatic dicarboxylic acid derivatives |
| 01/16/2003 | US20030013702 Agents and methods for treatment of cancer |
| 01/15/2003 | EP1062202B1 Cytostatic agents |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/14/2003 | CA2222303C Use of at least one no synthase inhibitor for treating sensitive skin |
| 01/09/2003 | WO2003002522A1 Peptide deformylase inhibitors |
| 01/09/2003 | US20030008900 Compounds and compositions for delivering active agents |
| 01/08/2003 | EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 01/08/2003 | EP1090150B1 Preparation of collector compositions of fatty hydroxamic acids in admixture with an oil for ore flotation |
| 01/07/2003 | US6504031 Enzyme inhibitor such as 6-(2-(1-isopropyl-1,2,3,4-tetrahydro -7-isoquinolinyl)ethenyl)-2-naphthalenecarboximidamide, used as angiogenesis inhibitors; antiarthritic, antiinflammatory and antitumor agents |
| 01/02/2003 | EP1268401A1 Process for the selective n-formylation of n-hydroxylamines |
| 01/02/2003 | EP1268393A2 Lipoxin analogs and methods for the treatment of periodontal disease |
| 01/02/2003 | EP0967867B1 Hydroximic acid halogenides, method for the production and use thereof |
| 01/02/2003 | EP0705245B1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 12/31/2002 | US6500983 For therapy of diseases or conditions mediated by over-production of or over-responsiveness to tumor necrosis factor (tnf) |
| 12/31/2002 | US6500823 Energy deficiency of the cell caused by parp inhibition, in diabetes complications, in oxygen deficient status of the heart and brain, in neurodegenerative diseases, in the treatment of autoimmune and/or viral diseases |
| 12/26/2002 | US20020198407 Antiallergy agents and bronchodilators |
| 12/24/2002 | CA2150812C Catechol diethers as selective pde iv inhibitors |